Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent

European Journal of Pharmacology

Volumn 303, Issue 1-2, 1996, Pages 55-59

  Hirasawa, Yoshimi ^a   Sugimoto, Toshiko ^a   Fukuyama, Shinichi ^a   Kato, Yasuko ^a   Takamatu, Hiroyuki ^a   Ohno, Mitsuko ^a   Nishino, Shigetaka ^a   Kato, Masayuki ^a   Maeda, Kazuhiro ^a   Seki, Jiro ^a   Kita, Yasuhiro ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Angina; FK409; FR144420; Nitric oxide (NO)

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ANTIANGINA PECTORIS AGENT; ARGIPRESSIN; FR 144420; METHACHOLINE; NEW DRUG; NITRIC OXIDE; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DOSE TIME EFFECT RELATION; HEART RATE; INTRADUODENAL DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ST SEGMENT ELEVATION;

EID: 0029900015     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00105-7     Document Type: Article

References (13)

1. Chung, S.-J. and H.-L. Fung, 1992, A common enzyme may be responsible for the conversion of organic nitrates to nitric oxide in vascular microsomes, Biochem. Biophys. Res. Commun. 185, 932.
2. Hatano, N., K. Nakatsuji, I. Nose and M. Shimizu, 1980, Effect of antianginal agents on electrocardiographic change induced with vasopressin in rats, Pharmacometrics 19, 311.
3. Hino, N., M. Iwami, M. Okamoto, K. Yoshida, H. Haruta, M. Okuhara, J. Hosoda, M. Kohsaka, H. Aoki and H. Imanaka, 1989, FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus, I. Taxonomy, fermentation, isolation, and physio-chemical and biological characteristics J. Antibiotics 42, 1578.
4. Hiramatsu, Y., A. Izumi, T. Tezuka and Y. Kurosawa, 1970, Antagonizing substances obtained from whale heart extract to vasopressin induced myocardial hypoxia, Jpn. J. Pharmacol. 20, 313.
5. Isono, T., N. Sato, Y. Koibuchi, S. Sakai, T. Yamamoto, R. Ozaki, J. Mori, M. Kohsaka and M. Ohtsuka, 1993, Effects of FK409, a novel nitric oxide donor, on acute experimental myocardial ischemia, Jpn. J. Pharmacol. 62, 315.
6. Kita, Y., Y. Hirasawa, K. Maeda, M. Nishio and K. Yoshida, 1994a, Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409, Eur. J. Pharmacol. 257, 123.
7. Kita, Y., R. Ozaki, S. Sakai, T. Sugimoto, Y. Hirasawa, M. Ohtsuka, H. Senoh, K. Yoshida and K. Maeda, 1994b, Antianginal effects of FK409, a new spontaneous NO releaser, Br. J. Pharmacol. 113, 1137.
8. Kita, Y., K. Ohkubo, Y. Hirasawa, Y. Katayama, M. Hamano, S. Nishino, M. Kato and K. Yoshida, 1995, FR144420; a novel, slow, nitric oxide-releasing agent, Eur. J. Pharmacol. 275, 125.
9. Nielsen, C.B., H. Eiskjaer and E.B. Pedersen, 1993, Enhanced renal production of cyclic GMP and reduced free water clearance during sodium nitroprusside, Eur. J. Clin. Invest. 23, 375.
10. Parker, J.D., B. Farrell, T. Fenton and J.O. Parker, 1992, Effects of diuretic therapy on the development of tolerance during continuous therapy with nitroglycerin, J. Am. Coll. Cardiol. 20, 616.
11. Rothman, M.T. and B. Khan, Summer 1991, Coronary artery spasm, Br. J. Clin. Pract. 45, 129.
12. Sakai, K., M. Akima and J. Aono, 1981, Evaluation of drug effects in a new experimental model of angina pectoris in the intact anesthetized rat, J. Pharmacol. Meth. 5, 325.
13. Winbury, M.M., B.B. Howe and M.A. Hefner, 1969, Effect of nitrates and other coronary dilators on large and small coronary vessels: An hypothesis for the mechanism of action of nitrates, J. Pharmacol. Exp. Ther. 168, 70.